News

GHLabs x GADx: PoC innovation in molecular diagnostics

The sensitivity of molecular testing is now being revolutionised for point-of-care (PoC) usage. PCR, known for its high sensitivity and specificity, is the gold standard in diagnosing many infectious diseases. However, its availability has been…

New CEO at GADx, Dr Mark Street-Docherty

New CEO at GADx, Dr Mark Street-Docherty

It is with great pleasure that Mologic Ltd t/a Global Access Diagnostics (GADx), announces the appointment of our new CEO, starting 1st February 2024, Dr Mark Street-Docherty.  Mark brings with him enormous experience of leading…

Packets of the IT-Leish rapid diagnostic test (RDT) for visceral leishmaniasis are displayed against a gradient background transitioning from teal to purple. Each white packet is clearly labeled with identification details including "IT LEISH", lot numbers, and expiration dates, along with the IVD (in vitro diagnostic) symbol, emphasizing their use in medical diagnostics. The packets are partially overlapped, focusing on their essential information and sterile packaging.

GADx reintroduces IT LEISH, the rapid diagnostic test for visceral leishmaniasis

Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics, today announced the launch of IT LEISH, a rapid diagnostic test (RDT) for visceral leishmaniasis (VL). The company acquired the manufacturing rights for…

COVI-GO-1920w

COVID-19 Rapid Antigen Self-Test, COVI-Go™, receives FDA Emergency Use Authorization for home use

Mologic Inc., the US subsidiary of  Global Access Diagnostics (GADx), a leading developer of lateral flow and rapid diagnostic technologies, products and services, announced today that its proprietary COVI-Go™ SARS-CoV-2 Ag Self-Test received Emergency Use…

Detecting Multiple Diseases At Once: EU-Funded Didida Project Develops A Cost-Effective Mobile Based Solution In Africa

Detecting multiple diseases at once: EU-funded DIDIDA project develops a cost-effective mobile based solution in Africa

The Digital Innovations and Diagnostics for Infectious Diseases in Africa (DIDIDA) had its official kick-off at the Strathmore University. DIDIDA is an ambitious project to develop reliable, low-cost, mobile phone-connected tests to help detect multiple…

Packets of the IT-Leish rapid diagnostic test (RDT) for visceral leishmaniasis are displayed against a gradient background transitioning from teal to purple. Each white packet is clearly labeled with identification details including "IT LEISH", lot numbers, and expiration dates, along with the IVD (in vitro diagnostic) symbol, emphasizing their use in medical diagnostics. The packets are partially overlapped, focusing on their essential information and sterile packaging.

GADx acquires manufacturing rights for IT LEISH rapid diagnostic test from Bio-Rad Laboratories

Global Access Diagnostics (GADx), a social enterprise prioritising equitable access to diagnostics and driving local manufacturing, today announced it has acquired the manufacturing rights for the IT LEISH rapid diagnostic test (RDT) for visceral leishmaniasis…

GADx formed to expand affordable access to advanced rapid diagnostic technologies

Global Access Health (GAH), a social enterprise dedicated to providing affordable medical products for global health, today formally introduced its first portfolio company, Global Access Diagnostics (GADx). GADx has been created to address gaps in…

Mologic partners with FINDdx for schistosomiasis rapid test

Mologic partners with FINDdx for schistosomiasis rapid test

Neglected Tropical Diseases affect more than one billion people worldwide, in some of the poorest areas. According to the World Health Organisation, schistosomiasis is a disease of poverty that leads to chronic ill health and…

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

Mologic and Alamar Biosciences collaborate to develop a next generation COVID-19 antigen test

Alamar Biosciences (Alamar), a platform company focused on transforming the field of proteomics to enable the early detection of cancer and other diseases, and Mologic, Ltd. (Mologic), part of the recently formed social enterprise Global…

An abstract representation of evolving pathways with diverging and converging lines that illustrate GADx's journey from inception to its current state and towards future opportunities. The design symbolizes strategic shifts, growth, and evolution under different leaderships, using a combination of flowing paths that embody progression and innovation. The image conveys an optimistic tone, highlighting the company's continuous forward movement and adaptation through changes in leadership.

Mologic to become a ‘Social Enterprise’ after acquisition by social impact funders and investors

A group of philanthropic funds and investors led by the Soros Economic Development Fund (SEDF), with support from the Bill & Melinda Gates Foundation, is today announcing the launch of Global Access Health (GAH), a…